PG vs. BMY
PG (The Procter & Gamble Company) and BMY (Bristol-Myers Squibb Company) are both stocks. PG operates in Household & Personal Products (Consumer Defensive), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, PG returned 8.53%/yr vs 1.24%/yr for BMY. At a 0.36 correlation, their price movements are largely independent.
Performance
PG vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PG achieves a 5.59% return, which is significantly lower than BMY's 15.30% return. Over the past 10 years, PG has outperformed BMY with an annualized return of 8.53%, while BMY has yielded a comparatively lower 1.24% annualized return.
PG
- 1D
- -0.57%
- 1M
- -0.83%
- 6M
- 4.70%
- YTD
- 5.59%
- 1Y
- -1.76%
- 3Y*
- 1.56%
- 5Y*
- 4.00%
- 10Y*
- 8.53%
- ALL TIME*
- 10.13%
BMY
- 1D
- -0.95%
- 1M
- 12.67%
- 6M
- 11.23%
- YTD
- 15.30%
- 1Y
- 33.12%
- 3Y*
- 2.32%
- 5Y*
- 1.91%
- 10Y*
- 1.24%
- ALL TIME*
- 9.27%
PG vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PG The Procter & Gamble Company | 5.59% | -12.26% | 17.25% | -0.86% | -5.05% | 20.52% | 14.15% | 39.70% | 3.57% | 12.69% |
BMY Bristol-Myers Squibb Company | 15.30% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between PG and BMY is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 1972 | 0.36 |
Fundamentals
PG:
$347.29B
BMY:
$122.85B
PG:
$5.24
BMY:
$3.56
PG:
28.45
BMY:
16.88
PG:
6.96
BMY:
0.96
PG:
4.17
BMY:
2.53
PG:
6.68
BMY:
6.13
PG:
$86.72B
BMY:
$48.48B
PG:
$43.64B
BMY:
$33.33B
PG:
$22.63B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PG vs. BMY — Risk / Return Rank
PG
BMY
PG vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Procter & Gamble Company (PG) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PG | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.28 | ||
| Sortino ratioReturn per unit of downside risk | -1.85 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.22 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.11 | 2.66 | -2.77 |
| Martin ratioReturn relative to average drawdown | -0.20 | 5.80 | -6.00 |
Loading charts...
Drawdowns
PG vs. BMY - Drawdown Comparison
The maximum PG drawdown since its inception was -54.25%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for PG and BMY.
Loading charts...
Drawdown Indicators
| PG | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.25% | -72.03% | +17.78% |
Max Drawdown (1Y)Largest decline over 1 year | -15.52% | -12.53% | -2.99% |
Max Drawdown (3Y)Largest decline over 3 years | -21.15% | -36.02% | +14.87% |
Max Drawdown (5Y)Largest decline over 5 years | -23.77% | -47.67% | +23.90% |
Max Drawdown (10Y)Largest decline over 10 years | -23.77% | -47.67% | +23.90% |
Current DrawdownCurrent decline from peak | -13.57% | -12.45% | -1.12% |
Average DrawdownAverage peak-to-trough decline | -12.17% | -22.37% | +10.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.87% | 5.73% | +3.14% |
Volatility
PG vs. BMY - Volatility Comparison
The current volatility for The Procter & Gamble Company (PG) is 7.35%, while Bristol-Myers Squibb Company (BMY) has a volatility of 10.52%. This indicates that PG experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PG | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.35% | 10.52% | -3.17% |
Volatility (6M)Calculated over the trailing 6-month period | 15.86% | 19.74% | -3.88% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.69% | 28.11% | -8.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.08% | 24.46% | -6.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.17% | 25.47% | -6.30% |
Dividends
PG vs. BMY - Dividend Comparison
PG's dividend yield for the trailing twelve months is around 2.15%, less than BMY's 4.17% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.17% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
PG The Procter & Gamble Company | 2.15% | 2.91% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.31% |
Financials
PG vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between The Procter & Gamble Company and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PG vs. BMY - Profitability Comparison
PG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, The Procter & Gamble Company reported a gross profit of 10.51B and revenue of 21.24B. Therefore, the gross margin over that period was 49.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
PG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, The Procter & Gamble Company reported an operating income of 4.58B and revenue of 21.24B, resulting in an operating margin of 21.6%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
PG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, The Procter & Gamble Company reported a net income of 18.50M and revenue of 21.24B, resulting in a net margin of 0.1%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
PG and BMY have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (10.52%) compared to PG (7.35%). In terms of maximum drawdown, PG dropped -54.25% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (1.19 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PG and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer